FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry, specifically to novel heterocyclic compounds of formula I or to their isomers or pharmaceutically acceptable salts, where R4 is F, R5 is H or C1-C4 alkyl substituted with 0 F, and n is 0, 1, 2 or 3. Also described is a pharmaceutical composition based on the compound of formula I and use of the compound of formula I as a monoamine level modulator.
formula I.
EFFECT: technical result is obtaining novel 3-benzyl-azetidine derivatives, useful for modulation of monoamine levels.
15 cl, 32 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
3-PHENYL-3-METHOXYPYRROLIDINE DERIVATIVES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION | 2009 |
|
RU2524214C2 |
CHROMENONE COMPOUNDS AS PI3-KINASE INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2598028C2 |
KINASE INHIBITORS | 2005 |
|
RU2348635C2 |
INDOLES AS 5-HT MODULATORS | 2007 |
|
RU2449990C2 |
NEW COMPOUNDS FOR THE TREATMENT OF MAMMALIAN INFECTIONS | 2019 |
|
RU2798336C2 |
NOVEL HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2019 |
|
RU2769507C1 |
TETRASUBSTITUTED ALKENE COMPOUNDS AND USE THEREOF | 2016 |
|
RU2733741C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
N-PYRROLIDINYL-UREA, N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS | 2013 |
|
RU2677667C2 |
COMPOUNDS | 2016 |
|
RU2725616C2 |
Authors
Dates
2020-03-17—Published
2016-05-20—Filed